STERIS plc (STE) Stock

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

STERIS plc is led by CEO Daniel A. Carestio, employs 17,937 people, headquartered in Dublin, IE, publicly traded since 1992.

STERIS plc (STE) stock trades at $234.83 with a market capitalization of $22.89B. The stock is valued at a price-to-earnings (P/E) ratio of 26.84, price-to-book of 2.90, price-to-sales of 3.57. Over the past 52 weeks the stock has ranged between $195.14 and $269.44, and currently trades 12.8% below its 52-week high. It pays a dividend yielding 1.14%.

On profitability, STERIS plc generates a return on equity (ROE) of 10.91%, return on capital employed of 15.31%, an operating margin of 18.56%, a net profit margin of 13.18%.

In its most recent fiscal year, STERIS plc reported annual revenue of $5.9B, net profit of $785.0M, revenue has compounded at 13.8% a year over the last five years, profit at 14.6% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.27 — a conservative balance sheet with little leverage risk, a current ratio of 2.09, total assets of $10.7B, $440.0M in cash and equivalents.

STE has an average daily trading volume of 801,450 shares, a beta of 0.92.

Official website: www.steris.com